Candesartan Cilexetil
Who holds supplier records for Candesartan Cilexetil? 17 organisations hold a current record for Candesartan Cilexetil: an active US FDA Type II Drug Master File or a CEP. A further 11 organisations have only historical (inactive) DMF filings. 13 of them hold a valid EU Certificate of Suitability (14 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (8), China (5), Spain (1), Netherlands (1) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Candesartan Cilexetil: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/candesartan-cilexetil
Reading the evidence
- 17 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (17)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Candesartan Cilexetil. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ULKAR KIMYA SANAYII VE TICARET ASActive DMF 25216, 26996 · latest filing Mar 2013
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 23693, 18828 · latest filing Apr 2010
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 21507, 30240 · latest filing Feb 2016
- CHROMO LABORATORIES INDIA PRIVATE LTDIndiaCEPActive DMF 25797 · latest filing Feb 2012
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 24810 · latest filing Mar 2011
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 20400 · latest filing Apr 2007
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 25455 · latest filing Oct 2011
- ZHUHAI RUNDU PHARMACEUTICAL CO LTDChinaCEPActive DMF 37468 · latest filing Nov 2022
- LINHAI TIANYU PHARMACEUTICAL CO LTDChinaActive DMF 43453 · latest filing Jun 2026
- Torrent PharmaceuticalsIndia Company GMP cert on recordActive DMF 22672 · latest filing Mar 2009
- Jiangxi Synergy Pharmaceutical Co., LtdChinaCEPInactive DMF 23649 · latest filing Mar 2010
- SpainCEP Company GMP cert on record
- IndiaCEP
- IndiaCEP Company GMP cert on record
- NetherlandsCEP
- ChinaCEP
- KRKA, d.d.SloveniaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (14)
Certificates of Suitability on the EDQM register for Candesartan Cilexetil, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 25 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. Zhuhai | CN | CEP 2023-096 - Rev 02 Candesartan cilexetil, Process 2 | Sept 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2019-303 - Rev 05 Candesartan cilexetil, Process II | May 2026 | — |
| JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. Yichun | CN | CEP 2013-007 - Rev 05 Candesartan cilexetil | Jun 2025 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 2019-297 - Rev 03 Candesartan cilexetil, Process-IV | May 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2011-248 - Rev 03 Candesartan cilexetil, Form I | Jan 2025 | — |
| ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou City | CN | CEP 2013-256 - Rev 03 Candesartan cilexetil | Sept 2024 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | CEP 2011-309 - Rev 05 Candesartan cilexetil, Sieving and non-sieving | Sept 2024 | Inspected May 2026 Italy |
| SMILAX LABORATORIES LIMITED Hyderabad | IN | CEP 2022-171 - Rev 00 Candesartan cilexetil | Mar 2024 | — |
| KRKA, d.d., Novo mesto Novo mesto | SI | CEP 2016-132 - Rev 01 Candesartan cilexetil | Feb 2024 | Inspected Jul 2025 Slovenia |
| CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram | IN | R1-CEP 2011-367 - Rev 03 Candesartan cilexetil | Jun 2023 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | R1-CEP 2011-266 - Rev 05 Candesartan cilexetil | May 2023 | — |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | R1-CEP 2014-042 - Rev 01 Candesartan cilexetil | Jan 2023 | — |
| ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. Sanzao Town | CN | R1-CEP 2013-314 - Rev 01 Candesartan cilexetil | Jan 2021 | — |
| QUIMICA SINTETICA S.A. Alcala De Henares | ES | R1-CEP 2013-228 - Rev 02 Candesartan cilexetil | Jun 2020 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (11)
Organisations whose Type II DMFs for Candesartan Cilexetil are no longer active. These show a past filing, not current supply.
Show all 11 historical records
- India · Inactive DMF 25219 · filed Aug 2011
- India · Inactive DMF 24770 · filed Mar 2011
- India · Inactive DMF 24296 · filed Nov 2010
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 23941 · filed Jul 2010
- India · Inactive DMF 23775 · filed May 2010
- India · Inactive DMF 21374 · filed May 2008
- Teva Pharmaceutical Industries Ltd.Israel · Inactive DMF 21069 · filed Nov 2007
- RANBAXY LABORATORIES LTDInactive DMF 20091 · filed Dec 2006
- Slovenia · Inactive DMF 20053 · filed Dec 2006
- India · Inactive DMF 19990 · filed Nov 2006
- ASTRA MERCK INCInactive DMF 11487 · filed May 1995
Overview
Candesartan Cilexetil is a prodrug that is hydrolyzed to candesartan during absorption from the gastrointestinal tract. It is an angiotensin II receptor blocker used to treat hypertension and heart failure.
Chemical identity
- IUPAC name
- 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
- Canonical SMILES
- CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OC(C)OC(=O)OC6CCCCC6
- InChIKey
- GHOSNRCGJFBJIB-UHFFFAOYSA-N
- Synonyms
- Atacand API, atacand, nsc-758697, tcv-116
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Angiotensin 2 Receptor Blocker
- Mechanism of action
- Angiotensin 2 Receptor Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Candesartan Cilexetil?
17 organisations hold an active US FDA Type II Drug Master File or a CEP for Candesartan Cilexetil: ULKAR KIMYA SANAYII VE TICARET AS, Zydus Lifesciences Limited (India), Alembic Pharmaceuticals Limited (India), CHROMO LABORATORIES INDIA PRIVATE LTD (India), Macleods Pharmaceuticals Ltd. (India), MATRIX PHARMACORP PRIVATE LTD (India), Zhejiang Huahai Pharmaceutical Co., Ltd. (China) and ZHUHAI RUNDU PHARMACEUTICAL CO LTD (China), and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Candesartan Cilexetil Drug Master Files are active?
ULKAR KIMYA SANAYII VE TICARET AS (DMF 25216, 26996), Zydus Lifesciences Limited (DMF 23693, 18828), Alembic Pharmaceuticals Limited (DMF 21507, 30240), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 25797), Macleods Pharmaceuticals Ltd. (DMF 24810), MATRIX PHARMACORP PRIVATE LTD (DMF 20400), Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 25455) and ZHUHAI RUNDU PHARMACEUTICAL CO LTD (DMF 37468) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Candesartan Cilexetil records mean?
11 organisations have only inactive Type II DMFs for Candesartan Cilexetil. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Candesartan Cilexetil have a European Certificate of Suitability?
Yes. 13 organisations hold a valid CEP for Candesartan Cilexetil on the EDQM register, including ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. Zhuhai (CN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. Yichun (CN), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN), TAPI NL B.V. Amsterdam (NL) and ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou City (CN) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Candesartan Cilexetil supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Candesartan Cilexetil?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.